Dr. Emil Engels
AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic Indications
December 29, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Dec. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in biotechnology cannabinoid research and development, announced today the addition...